African countries

WHO Director-General: African countries like Egypt are capable of producing vaccines and biologicals on a large scale

WHO logo – CC via Wikimedia

CAIRO – April 16, 2022: World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus said African countries like Egypt, Kenya, Nigeria, Senegal and Tunisia will be in able to produce vaccines and biologics on a large scale.

In his Remarks During the briefing of African Union Ambassadors in Geneva on strengthening local manufacturing capacities on Thursday, the Director-General said he was impressed by the capacity of this public-private partnership and convinced that African countries will be able to produce vaccines and biologics at scale.

In February 2022, the Director General of the WHO announced that six African countries including Egyptian Tunisia would receive “mRNA” technology to locally produce vaccines against the coronavirus.

“The Global mRNA Technology Transfer Center was established in 2021 to help manufacturers in low- and middle-income countries produce their own vaccines, ensuring they have all the operational procedures and know-how necessary to manufacture mRNA vaccines on a large scale and according to international standards,” the WHO said.

President Abdel Fattah El Sisi welcomed that Egypt has been selected among the countries on the African continent that will receive support to obtain mRNA technology used in the manufacture of vaccines and other important drugs to combat to many incurable diseases.

President Sisi’s appreciation was expressed in his speech at the WHO session on vaccine technology and health systems, on the sidelines of the EU-AU summit in Brussels in February.

Meanwhile, Tedros Adhanom Ghebreyesus mentioned Thursday, April 14, 2022, that Egypt, Japan and Thailand joined an Intergovernmental Negotiating Body (INB) being prepared to negotiate “a WHO convention, agreement or other international instruments to strengthen pandemic prevention, preparedness and response”.

He added that the results of the INB which was formed by the World Health Assembly in December 2021 would be submitted to the 2024 assembly.